AI assistant
Origin Enterprises Plc — Remuneration Information 2020
Jul 8, 2020
1973_def-14a_2020-07-08_293f0761-63c1-4844-8b1d-1141818c0024.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 4488S
Origin Enterprises Plc
08 July 2020
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Sean Coyle
2
Reason for the notification
a)
Position/status
Chief Executive Officer / PDMR
b)
Initial Notification Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Origin Enterprises plc
b)
LEI
213800AIB4U7N5BLS350
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument,
type of
instrument
Identification code
Origin Enterprises plc Ordinary Shares of €0.01 each
IE00B1WV4493
b)
Nature of the transaction
Grant of options under the Origin Enterprises plc Long Term Incentive Plan 2015
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| €0.01 | 222,246 |
d)
Aggregated information
- Aggregated volume
- Price
Not applicable - single transaction
e)
Date of the transaction
8 July 2020
f)
Place of the transaction
Outside a trading venue
g)
Additional Information
Options are exercisable from 8 July 2023 to 7 July 2027
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHFLFVEDAITIII